The BDNF Val66Met polymorphism: Relation to familiar risk of affective disorder, BDNF levels and salivary cortisol

Psychoneuroendocrinology

Volumn 34, Issue 9, 2009, Pages 1380-1389

  Vinberg, Maj ^a   Trajkovska, Viktorija ^b   Bennike, Bente ^a   Knorr, Ulla ^a   Knudsen, Gitte M ^b   Kessing, Lars V ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

BDNF; BDNF Val66Met; Cortisol; Familiar risk; HPA axis; Mood disorder

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HYDROCORTISONE; METHIONINE; VALINE;

ADULT; ALLELE; ARTICLE; BECK DEPRESSION INVENTORY; BIPOLAR DISORDER; BLOOD LEVEL; CONTROLLED STUDY; DIZYGOTIC TWINS; EYSENCK PERSONALITY QUESTIONNAIRE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAMILTON SCALE; HIGH RISK PATIENT; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOZYGOTIC TWINS; MOOD DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SALIVA LEVEL; STRESS;

ADULT; ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYDROCORTISONE; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; MOOD DISORDERS; POLYMORPHISM, GENETIC; SALIVA; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 69849094618     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.04.014     Document Type: Article

References (58)

1. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
2. Begliuomini S., Lenzi E., Ninni F., Casarosa E., Merlini S., Pluchino N., et al. Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J. Endocrinol. 197 2 (2008) 429-435
3. Belmaker R.H., and Agam G. Major depressive disorder. N. Engl. J. Med. 358 1 (2008) 55-68
4. Brunoni A.R., Lopes M., and Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11 8 (2008) 1169-1180
5. Chepenik L.G., Fredericks C., Papademetris X., Spencer L., Lacadie C., Wang F., et al. Effects of the brain-derived neurotrophic growth factor Val66Met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 34 4 (2008) 944-951
6. Christensen M.V., and Kessing L.V. The hypothalamo-pituitary-adrenal axis in major affective disorder: a review. Nord. J. Psychiatry 55 5 (2001) 359-363
7. Christensen M.V., Kyvik K.O., and Kessing L.V. Cognitive function in unaffected twins discordant for affective disorder. Psychol. Med. 36 8 (2006) 1119-1129
8. Christensen M.V., Kyvik K.O., and Kessing L.V. Subclinical psychopathology and socio-economic status in unaffected twins discordant for affective disorder. J. Psychiatry Res. 41 (2007) 229-238
9. Clements A.D., and Parker C.R. The relationship between salivary cortisol concentrations in frozen versus mailed samples. Psychoneuroendocrinology 23 6 (1998) 613-616
10. Cunha A.B.M., Frey B.N., Andreazza A.C., Goi J.D., Rosa A.R., Goncalves C.A., et al. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett. 398 (2006) 215-219
11. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 2 (2003) 257-269
12. Eysenck H.J. Manual of the Eysenck Personality Questionnaire (1975), Hodder and Staughton, London
13. Fan J., and Sklar P. Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism. Novartis Found. Symp. 289 (2008) 60-72
14. Farmer A., Eley T.C., and McGuffin P. Current strategies for investigating the genetic and environmental risk factors for affective disorders. Br. J. Psychiatry 186 (2005) 179-181
15. Frodl T., Schule C., Schmitt G., Born C., Baghai T., Zill P., et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry 64 4 (2007) 410-416
16. Gatt J.M., Nemeroff C.B., Dobson-Stone C., Paul R.H., Bryant R.A., Schofield P.R., et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol. Psychiatry (2009) 1-15
17. Goodyer I.M., Herbert J., Altham P.M., Pearson J., Secher S.M., and Shiers H.M. Adrenal secretion during major depression in 8- to 16-year-olds. I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol. Med. 26 2 (1996) 245-256
18. Goodyer I.M., Herbert J., Tamplin A., and Altham P.M. First-episode major depression in adolescents. Affective, cognitive and endocrine characteristics of risk status and predictors of onset. British Journal of Psychiatry 176 (2000) 142-149
19. Gotlib I.H., Joormann J., Minor K.L., and Hallmayer J. HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol. Psychiatry 63 9 (2008) 847-851
20. Groves J.O. Is it time to reassess the BDNF hypothesis of depression?. Mol. Psychiatry 12 12 (2007) 1079-1088
21. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
22. Harvald B., Hauge G., Kyvik K.O., Christensen K., Skytthe A., and Holm N.V. The Danish twin registry: past and present. Twin. Res. 7 4 (2004) 318-335
23. Hasin D.S., Goodwin R.D., Stinson F.S., and Grant B.F. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch. Gen. Psychiatry 62 10 (2005) 1097-1106
24. Hong C.J., Huo S.J., Yen F.C., Tung C.L., Pan G.M., and Tsai S.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behaviour. Neuropsychobiology 48 4 (2003) 186-189
25. Kapczinski F., Frey B.N., Kauer-Sant'anna M., and Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert. Rev. Neurother. 8 7 (2008) 101-1113
26. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G., and Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109 2 (2002) 143-148
27. Kendler K.S., Kessler R.C., Walters E.E., MacLean C., Neale M.C., Heath A.C., et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am. J. Psychiatry 152 6 (1995) 833-842
28. Kirschbaum C., and Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 19 4 (1994) 313-333
29. Lang U.E., Hellweg R., and Gallinat J. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29 4 (2004) 795-798
30. Lang U.E., Hellweg R., Sander T., and Gallinat J. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol. Psychiatry 14 2 (2009) 120-122
31. Lommatzsch M., Zingler D., Schuhbaeck K., Schloetcke K., Zingler C., Schuff-Werner P., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 26 1 (2005) 115-123
32. Martinowich K., and Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33 1 (2008) 73-83
33. Merikangas K.R., and Low N.C. The epidemiology of mood disorders. Curr. Psychiatry Rep. 6 6 (2004) 411-421
34. Mortensen P.B., Pedersen C.B., Melbye M., Mors O., and Ewald H. Individual and familial risk factors for bipolar affective disorders in Denmark. Arch. Gen. Psychiatry 60 12 (2003) 1209-1215
35. Munk-Jorgensen P., and Mortensen P.B. The Danish Psychiatric Central Register. Dan. Med. Bull. 44 1 (1997) 82-84
36. Nemeroff C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry 1 4 (1996) 336-342
37. Piccinni A., Marazziti D., Debbio A., Del C., Bianchi I., Roncaglia, et al. Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol. Int. 25 5 (2008) 819-826
38. Pini S., Queiroz de V., Pagnin D., Pezawas L., Angst J., Cassano G.B., et al. Prevalence and burden of bipolar disorders in European countries. Eur. Neuropsychopharmacol. 15 4 (2005) 425-434
39. Post R.M. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J. Psychiatr. Res. 41 12 (2007) 979-990
40. Schule C., Zill P., Baghai T.C., Eser D., Zwanzger P., Wenig N., et al. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients. Psychoneuroendocrinology 31 8 (2006) 1019-1025
41. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 58 4 (2005) 307-314
42. Sen S., Duman R., and Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 64 6 (2008) 527-532
43. Shalev I., Lerer E., Israel S., Uzefovsky F., Gritsenko I., Mankuta D., et al. BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions. Psychoneuroendocrinology 34 (2009) 382-388
44. Shelton R.C. The molecular neurobiology of depression. Psychiatry Clin. North Am. 30 1 (2007) 1-11
45. Strauss J., Barr C.L., George C.J., King N., Shaikh S., Devlin B., Kovacs M., and Kennedy J.L. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. Am. J. Med. Genet. B Neuropsychiatry Genet. 131 1 (2004) 16-19
46. Strickland P.L., Deakin J.F., Percival C., Dixon J., Gater R.A., and Goldberg D.P. Bio-social origins of depression in the community. Interactions between social adversity, cortisol and serotonin neurotransmission. Br. J. Psychiatry 180 (2002) 168-173
47. Thoenen H. Neurotrophins and neuronal plasticity. Science 270 5236 (1995) 593-598
48. Trajkovska V., Marcussen A.B., Vinberg M., Hartvig P., Aznar S., and Knudsen G.M. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res. Bull. 73 (2007) 143-149
49. Trajkovska V., Vinberg M., Aznar S., Knudsen G.M., and Kessing L.V. Whole blood BDNF levels in healthy twins discordant for affective disorder: association to life events and neuroticism. J. Affect. Disord. 108 (2008) 165-169
50. Tsai S.J., Cheng C.Y., Yu Y.W., Chen T.J., and Hong C.J. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am. J. Med. Genet. B Neuropsychiatry Genet. 123B 1 (2003) 19-22
51. Verhagen M., van der Meij A., van Deurzen P.A., Janzing J.G., Aias-Vasquez A., et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol. Psychiatry (2008) (Epub ahead of print)
52. Vinberg M., Bennike B., Kyvik K.O., Andersen P.K., and Kessing L.V. Salivary cortisol in unaffected twins discordant for affective disorder. Psychiatry Res. 161 3 (2008) 292-301
53. Yoshimura R., Mitoma M., Sugita A., Hori H., Okamoto T., Umene W., et al. Effects of paraxetine or milnacipran in serum brain-derived neutrophic factor in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2007) 1034-1037
54. Weissman M.M., Wickramaratne P., Adams P., Wolk S., Verdeli H., and Olfson M. Brief screening for family psychiatric history: the family history screen. Arch. Gen. Psychiatry 57 7 (2000) 675-682
55. Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., et al. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch. Gen. Psychiatry 47 6 (1990) 589-593
56. World Health Organization, 1967. Manual of the International Classification of Diseases, 8th revision (ICD-8). Genova, Schweitzerland.
57. World Health Organization, 2005. International Classification of Diseases, 10th revision (ICD-10). Genova, Schweitzerland.
58. Ziegenhorn A.A., Schulte-Herbruggen O., Danker-Hopfe H., Malbranc M., Hartung H.D., Anders D., Lang U.E., et al. Serum neurotrophins-a study on the time course and influencing factors in a large old age sample. Neurobiol. Aging 28 9 (2007) 1436-1445